Respiratory distress and Attention deficit hyperactivity disorder

Summary:

Attention deficit hyperactivity disorder is reported only by a few people with Respiratory distress.

The study analyzes which people have Attention deficit hyperactivity disorder with Respiratory distress. It is created by eHealthMe based on 3 people who have Attention deficit hyperactivity disorder and Respiratory distress from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 27, 2022

3 people who have Respiratory Distress and Attention Deficit Hyperactivity Disorder are studied.


What is Respiratory distress?

Respiratory distress (difficulty in breathing) is found to be associated with 2,234 drugs and 1,795 conditions by eHealthMe.

What is Attention deficit hyperactivity disorder?

Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 1,460 drugs and 1,182 conditions by eHealthMe.

Number of Attention deficit hyperactivity disorder in Respiratory distress reports submitted per year:

Would you have Attention deficit hyperactivity disorder when you have Respiratory distress?

Gender of people who have Respiratory Distress and experienced Attention Deficit Hyperactivity Disorder *:

  • female: 100 %
  • male: 0.0 %

Common co-existing conditions for these people *:

  1. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 100.00%
  2. Cystic Fibrosis (disease of the secretary glands): 3 people, 100.00%
  3. Cough: 3 people, 100.00%
  4. Breathing Difficulty: 3 people, 100.00%

Common drugs taken by these people *:

  1. Orkambi: 3 people, 100.00%
  2. Sodium Chloride: 1 person, 33.33%
  3. Risperidone: 1 person, 33.33%
  4. Oxcarbazepine: 1 person, 33.33%
  5. Fluticasone Propionate: 1 person, 33.33%
  6. Cetirizine Hydrochloride: 1 person, 33.33%
  7. Albuterol Sulfate: 1 person, 33.33%

Common symptoms for these people *:

  1. Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Attention deficit hyperactivity disorder?

Check whether Attention deficit hyperactivity disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Attention deficit hyperactivity disorder:

Common drugs associated with Attention deficit hyperactivity disorder:

All the drugs that are associated with Attention deficit hyperactivity disorder:

Common conditions associated with Attention deficit hyperactivity disorder:

All the conditions that are associated with Attention deficit hyperactivity disorder:

How the study uses the data?

The study is based on Attention deficit hyperactivity disorder and Respiratory distress, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: